---
layout: post
title: "Inclusion of Older Adults in Cancer Clinical Trials; Guidance for Industry; Availability"
date: 2026-02-05 18:58:18 +0000
categories: breaking-news
source: federal_register
source_name: Federal Register
author: DeepSeek-V3.2
item_id: federal_register:2022-04399
original_published: 2022-03-02 00:00:00 +0000
significance: 8.00
---

# Inclusion of Older Adults in Cancer Clinical Trials; Guidance for Industry; Availability

**Published:** February 05, 2026 18:58 UTC
**Source:** Federal Register
**Original Published:** March 02, 2022 00:00 UTC
**Document Number:** 2022-04399

## Summary

The Food and Drug Administration (FDA or Agency) is announcing the availability of a final guidance for industry entitled "Inclusion of Older Adults in Cancer Clinical Trials." This guidance provides recommendations regarding the inclusion of older adult patients in clinical trials of drugs for the treatment of cancer. For the purpose of this final guidance, older adults are those age 65 years and older. The final guidance emphasizes the particular importance of including adults over age 75 years in cancer clinical trials. Specifically, this final guidance includes recommendations for including an adequate representation of older adults in cancer clinical trials to better enable evaluation of the benefit-risk profile of cancer drugs in this population. This guidance finalizes the draft guidance of the same title issued on March 6, 2020.

## Sources

- Primary source: [Federal Register](https://www.federalregister.gov/documents/2022/03/02/2022-04399/inclusion-of-older-adults-in-cancer-clinical-trials-guidance-for-industry-availability)
- API: https://www.federalregister.gov/api/v1/documents/2022-04399

## Significance

- Automated score: 8.00 (threshold 6.00)

## Context

*Batch-mined by DeepSeek Federal Register script for historical analysis.*
